About 100 Mg Irinotecan Injection IP
Get transcendent cancer care with the splendiferous 100 Mg Irinotecan Injection IP-a decorated solution designed for intravenous infusion. Offered in a ready-to-use single dose vial (100 mg/5 ml), this antineoplastic agent effectively addresses colorectal cancer and other solid tumors. For a limited time, advance purchase is recommended for distributors, exporters, suppliers, and traders in India. The injection must be diluted and administered intravenously under strict medical supervision. Not for patients with known hypersensitivity to irinotecan or its excipients; exercise caution in hepatic impairment. Experience excellence, but only by prescription-order completion secured within regulatory compliance.
Clinical Applications and Machine Features
100 Mg Irinotecan Injection IP is chiefly used for the management of colorectal cancer and other solid tumors. Its advanced formulation includes Irinotecan Hydrochloride Trihydrate and a blend of stabilizers in water for injection, resulting in a clear or pale yellow, odorless solution. This injection fits seamlessly into modern chemotherapy protocols, offering a ready-to-use, single-dose vial designed for controlled intravenous administration via infusion pumps-ensuring precise, safe, and effective delivery.
Sample Policy, FOB Port, and Certification Essentials
Samples of 100 Mg Irinotecan Injection IP can be estimated upon established distributor relationships. The list price is provided upon request, with order completion handled professionally from India's major FOB ports. All batches comply with recognized certifications, ensuring quality, safety, and regulatory requirements are met. Reach out for sample availability and detailed documentation to facilitate trusted supply chains within domestic and export markets.
FAQ's of 100 Mg Irinotecan Injection IP:
Q: How should 100 Mg Irinotecan Injection IP be administered to patients?
A: 100 Mg Irinotecan Injection IP must be diluted and administered as an intravenous infusion under direct supervision of qualified healthcare professionals. Dosage and frequency depend on the individual's medical condition and treatment protocol.
Q: What conditions can be treated using this injection?
A: This injection is primarily indicated for colorectal cancer and selected other solid tumors. Its antineoplastic properties make it suitable for advanced chemotherapy regimens.
Q: When should the product not be used or cautioned?
A: The injection is contraindicated in patients with known hypersensitivity to irinotecan or any excipients present. Use with heightened caution in individuals with hepatic impairment or poor performance status, as advised by oncology guidelines.
Q: Where should 100 Mg Irinotecan Injection IP be stored after delivery?
A: It should be stored below 25C, protected from light, and must not be frozen to maintain its stability and efficacy throughout its 24-month shelf life.
Q: What certifications and documentation support the supply process?
A: Each batch is certified for quality and safety, aligning with pharmaceutical regulations. Documentation supporting certifications and regulatory compliance is provided during order completion for distributors and exporters.
Q: How can samples or bulk orders be requested and what is the process?
A: Distributors and suppliers can request samples or bulk estimates by contacting with details of their requirements. List price and order completion processes, including shipping from India's major FOB ports, are facilitated upon agreement.